Evidence map›Paper›PMID 31308664›Full record

ArticleInternational journal of nanomedicine2019

Encapsulation of a nanoporous simvastatin-chitosan composite to enhance osteointegration of hydroxyapatite-coated polyethylene terephthalate ligaments.

Xiaoquan Ding, Siheng Wang, Wenhe Jin, Xingwang Liu, Jun Chen, Shiyi Chen

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Engineering Functional Rat Ovarian Spheroids Using Granulosa and Theca Cells.Reproductive sciences (Thousand Oaks, Calif.) · 2021
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Xiaoquan DingCenter of Sports Medicine, Department of Sports Medicine, Huashan Hospital, Fudan University, Shanghai 200040, People's Republic of China.
Siheng WangCenter of Sports Medicine, Department of Sports Medicine, Huashan Hospital, Fudan University, Shanghai 200040, People's Republic of China.
Wenhe JinCenter of Sports Medicine, Department of Sports Medicine, Huashan Hospital, Fudan University, Shanghai 200040, People's Republic of China.
Xingwang LiuCenter of Sports Medicine, Department of Sports Medicine, Huashan Hospital, Fudan University, Shanghai 200040, People's Republic of China.
Jun ChenCenter of Sports Medicine, Department of Sports Medicine, Huashan Hospital, Fudan University, Shanghai 200040, People's Republic of China.
Shiyi ChenCenter of Sports Medicine, Department of Sports Medicine, Huashan Hospital, Fudan University, Shanghai 200040, People's Republic of China.
Huashan Hospital · CNFudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study was designed to evaluate the in vitro and in vivo biocompatibility and osteointegration of plasma-sprayed hydroxyapatite (HA)-coated polyethylene terephthalate (PET) ligaments encapsulated with a simvastatin (SV)-chitosan (CS) composite.

methodsThis study compared the in vitro and in vivo bone responses to three different PET ligaments: SV/CS/PET-HA, CS/PET-HA and PET-HA. A field emission scanning electron microscope was used to characterize the morphology, and the in vitro SV release profile was analyzed. MC3T3 cells were cocultured with SV/CS/PET-HA, CS/PET-HA and PET-HA to test their biocompatibility using CCK-8 tests. Osteogenic differentiation was investigated by the expression of marker genes using qPCR. Osteointegration was performed by implanting the PET ligaments into the proximal tibia bone tunnels of male Sprague-Dawley rats for 3 weeks and 6 weeks. The bone-implant interface was evaluated by micro-computed tomography (micro-CT) and histological analysis.

resultsThe characteristic nanoporous structures mainly formed on the surface of the plasma-sprayed HA particles in the SV/CS/PET-HA and CS/PET-HA groups. The SV release test showed that the sustained release of simvastatin lasted for 25 days in the SV/CS/PET-HA group. The in vitro studies demonstrated that the SV/CS/PET-HA ligaments induced osteogenic differentiation in the MC3T3 cells, with higher mRNA expression levels of collagen-1, bone morphogenetic protein-2, osteocalcin and alkaline phosphatase than those in the CS/PET-HA and PET-HA ligament groups. The in vivo tests showed that both micro-CT analysis (bone mineral density and bone volume per total volume) and histological analysis (bone implant contact and interface area) revealed significantly higher peri-implant bone formation and less interface area in the SV/CS/PET-HA group than in the other groups.

conclusionThe SV-CS composite nanoporous structure was associated with the improved biocompatibility and osteogenic differentiation in vitro and enhanced osteointegration process in vivo of plasma-sprayed HA-coated PET ligaments.

Indexed as

NanoporesAnimalsBone and BonesCell DifferentiationCell LineCell ProliferationChitosanDrug LiberationDurapatiteLigamentsMaleOsseointegrationOsteocalcinOsteogenesisPolyethylene TerephthalatesRats, Sprague-DawleyChitosanDurapatiteOsteocalcinPolyethylene TerephthalatesRNA, MessengerSimvastatinchitosanhydroxyapatiteosteointegrationpolyethylene terephthalatesimvastatin

Identifiers

PMID31308664
PMCPMC6613541
OpenAlexW2955594980

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.